475 related articles for article (PubMed ID: 33962960)
1. Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.
Smerilli G; Cipolletta E; Moscioni E; Francioso F; Risa AM; Maccarrone V; Zompa D; Di Matteo A; Di Carlo M; De Angelis R; Salaffi F; Filippucci E; Grassi W
Ann Rheum Dis; 2021 Oct; 80(10):e168. PubMed ID: 33962960
[No Abstract] [Full Text] [Related]
2. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli
Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.
Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
Ann Rheum Dis; 2021 Jul; 80(7):953-954. PubMed ID: 33622689
[No Abstract] [Full Text] [Related]
4. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
Boyarsky BJ; Ruddy JA; Connolly CM; Ou MT; Werbel WA; Garonzik-Wang JM; Segev DL; Paik JJ
Ann Rheum Dis; 2021 Aug; 80(8):1098-1099. PubMed ID: 33757968
[No Abstract] [Full Text] [Related]
6. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
Chiang TP; Connolly CM; Ruddy JA; Boyarsky BJ; Alejo JL; Werbel WA; Massie A; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
Ann Rheum Dis; 2021 Oct; 80(10):1365-1366. PubMed ID: 34429320
[No Abstract] [Full Text] [Related]
7. Correspondence on "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry" by Machado
Bourguiba R; Delplanque M; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
Ann Rheum Dis; 2023 Dec; 82(12):e228. PubMed ID: 35817471
[No Abstract] [Full Text] [Related]
8. Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases.
Connolly CM; Ruddy JA; Boyarsky BJ; Avery RK; Werbel WA; Segev DL; Garonzik-Wang J; Paik JJ
Ann Rheum Dis; 2021 Aug; 80(8):1100-1101. PubMed ID: 33741555
[No Abstract] [Full Text] [Related]
9. Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease.
Connolly CM; Frey S; Chiang TP; Teles M; Alejo JL; Albayda J; Shah AA; Werbel WA; Segev DL; Christopher-Stine L; Paik JJ
Rheumatology (Oxford); 2022 Oct; 61(10):e302-e304. PubMed ID: 35583259
[No Abstract] [Full Text] [Related]
10. Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases.
Ursini F; Ruscitti P; Raimondo V; De Angelis R; Cacciapaglia F; Pigatto E; Olivo D; Di Cola I; Galluccio F; Francioso F; Foti R; Tavoni A; D'Angelo S; Campochiaro C; Motta F; De Santis M; Bilia S; Bruno C; De Luca G; Visentini M; Ciaffi J; Mancarella L; Brusi V; D'Onghia M; Cuomo G; Fusaro E; Dagna L; Guiducci S; Meliconi R; Iannone F; Iagnocco A; Giacomelli R; Ferri C
Ann Rheum Dis; 2022 Mar; 81(3):440-441. PubMed ID: 34836886
[No Abstract] [Full Text] [Related]
11. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
Dejaco C; Bijlsma JW; Buttgereit F
Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
[No Abstract] [Full Text] [Related]
12. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
Al Nokhatha S; MacEoin N; Conway R
Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
[No Abstract] [Full Text] [Related]
13. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Schulze-Koops H; Specker C; Skapenko A
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
[TBL] [Abstract][Full Text] [Related]
14. Rheumatologists' knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey.
Fathi HM; Gazzar IIE; Elazeem MIA; AboulKheir E; Gamal NM; Ismail F; Shereef RRE; Tharwat S; Elwan S; Samy N; Baki NA; Elsaid NY; El-Bahnasawy AS; Moshrif A; Fattah YA; Amer MA; Ibrahim ME; Khalil NM; El-Dessouki S; Abaza N; El-Shanawany AT; Mohamed EF; El-Ghobashy N; Ayoub N; Hammam O; Fawzy S; Sayed S; Gheita TA; Hammam N;
Rheumatol Int; 2022 Jun; 42(6):989-998. PubMed ID: 35429291
[TBL] [Abstract][Full Text] [Related]
15. Use of Tofacitinib in the Context of COVID-19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases.
Mortezavi M; Menon S; Lee K; Rivas J
Arthritis Rheumatol; 2021 Sep; 73(9):1768-1769. PubMed ID: 34042319
[No Abstract] [Full Text] [Related]
16. Management of Patients With Inflammatory Rheumatic Diseases: Telemedicine and Rheumatologists Challenged in the Era of COVID-19.
Foti R; Amato G; Foti R; Visalli E
Front Public Health; 2020; 8():558838. PubMed ID: 33240833
[No Abstract] [Full Text] [Related]
17. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.
Curtis JR; Johnson SR; Anthony DD; Arasaratnam RJ; Baden LR; Bass AR; Calabrese C; Gravallese EM; Harpaz R; Kroger A; Sadun RE; Turner AS; Williams EA; Mikuls TR
Arthritis Rheumatol; 2021 Aug; 73(8):e30-e45. PubMed ID: 34128356
[TBL] [Abstract][Full Text] [Related]
18. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
Landewé RBM; Kroon FPB; Alunno A; Najm A; Bijlsma JW; Burmester GR; Caporali R; Combe B; Conway R; Curtis JR; Elkayam O; Gossec L; Heijstek MW; Haupt L; Iagnocco A; Isaacs JD; Juhász IÁ; Makri S; Mariette X; McInnes IB; Mehta P; Mueller-Ladner U; Schulze-Koops H; Smolen JS; Wiek D; Winthrop KL; Navarro-Compán V; Machado PM
Ann Rheum Dis; 2022 Dec; 81(12):1628-1639. PubMed ID: 35197264
[TBL] [Abstract][Full Text] [Related]
19. Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study.
Fragoulis GE; Grigoropoulos I; Mavrea E; Arida A; Bournia VK; Evangelatos G; Fragiadaki K; Karamanakos A; Kravvariti E; Panopoulos S; Pappa M; Thomas K; Tektonidou MG; Paraskevis D; Vassilopoulos D; Sfikakis PP
Rheumatol Int; 2021 May; 41(5):895-902. PubMed ID: 33661331
[TBL] [Abstract][Full Text] [Related]
20. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Agmon-Levin N; van Assen S; Bijl M; Kapetanovic MC; de Thurah A; Mueller-Ladner U; Paran D; Schreiber K; Warnatz K; Wulffraat NM; Elkayam O
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
